Read more

SOLITAIRE-IV: A Randomized, Double-Blind, Multi-Center Study Comparing the Efficacy and Safety of Intravenous-to-Oral Solithromycin to Intravenous-to-Oral Moxifloxacin for Treatment of Community-acquired Bacterial Pneumonia.

Related ArticlesSOLITAIRE-IV: A Randomized, Double-Blind, Multi-Center Study Comparing the Efficacy and Safety of Intravenous-to-Oral Solithromycin to Intravenous-to-Oral Moxifloxacin for Treatment of Community-acquired Bacterial Pneumonia.